Hirokazu Yago

Title: Hirokazu Yago: Innovator in Thrombin Stabilization and Adiponectin Assays

Introduction

Hirokazu Yago is a notable inventor based in Ryugasaki, Japan. He has made significant contributions to the field of biochemistry, particularly in the stabilization of thrombin and the selective assay of adiponectin multimers. With a total of six patents to his name, Yago's work has implications for medical diagnostics and therapeutic applications.

Latest Patents

Yago's latest patents include a method for stabilizing α-thrombin in thrombin-containing solutions. This innovative method aims to provide a solution that contains stabilized α-thrombin, which is crucial for various medical applications. The method involves adjusting the percentage of α-thrombin to 70% or more relative to the total thrombin in the solution. Another significant patent is the method of selectively assaying adiponectin multimers. This patent outlines kits and methods that accurately evaluate the relationship between diseases and adiponectin by selectively assaying target adiponectin multimers in biological samples. This approach provides valuable information that cannot be obtained through measuring the total amount of adiponectin alone.

Career Highlights

Throughout his career, Hirokazu Yago has worked with prominent companies such as Daiichi Pure Chemicals Co., Ltd. and Toudai Tlo, Ltd. His experience in these organizations has contributed to his expertise in biochemistry and patent development.

Collaborations

Yago has collaborated with notable colleagues, including Hiroyuki Ebinuma and Yuka Akimoto. These collaborations have likely enriched his research and innovation efforts.

Conclusion

Hirokazu Yago's contributions to the fields of thrombin stabilization and adiponectin assays highlight his role as a significant inventor. His patents reflect a commitment to advancing medical diagnostics and therapeutic methods.